Ignite Creation Date:
2024-05-06 @ 2:35 AM
Last Modification Date:
2024-10-26 @ 11:20 AM
Study NCT ID:
NCT02070653
Status:
COMPLETED
Last Update Posted:
2018-05-02
First Post:
2014-02-21
Brief Title:
The Efficacy of Ticagrelor on Abdominal Aortic Aneurysm AAA Expansion
Sponsor:
Uppsala University
Organization:
Uppsala University
Study Overview
Official Title:
Does Ticagrelor Inhibit Growth of Small Abdominal Aortic Aneurysms A Randomised Controlled Trial TicAAA
Status:
COMPLETED
Status Verified Date:
2018-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TicAAA
Brief Summary:
Abdominal aortic aneurysm AAA is a major health problem and ruptured AAA is a common cause of death in Europe and North America A key limitation of contemporary treatment strategies of AAA is the lack of therapy directed at reducing expansion Although surgical repair is an effective treatment for large AAA it is associated with significant mortality and morbidity as well as substantial cost The rationale for this randomized controlled study is to investigate whether treatment with Ticagrelor inhibits growth of small abdominal aortic aneurysms
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None